Literature DB >> 17885234

MR imaging of metronidazole-induced encephalopathy: lesion distribution and diffusion-weighted imaging findings.

E Kim1, D G Na, E Y Kim, J H Kim, K R Son, K H Chang.   

Abstract

BACKGROUND AND
PURPOSE: MR imaging features of metronidazole-induced encephalopathy (MIE) have not been fully established. This study was undertaken to determine the topographic distributions and diffusion-weighted imaging (DWI) findings of MIE.
MATERIALS AND METHODS: We retrospectively evaluated the initial MR images (n = 7), including DWI (n = 5), and follow-up MR images (n = 4) after drug discontinuation in 7 patents with clinically diagnosed MIE. The topographic distributions of lesions were evaluated on MR images, and DWI signal intensities and apparent diffusion coefficient (ADC) values of the lesions were assessed.
RESULTS: MR images demonstrated bilateral symmetric T2 hyperintense lesions in the cerebellar dentate nucleus (n = 7), midbrain (n = 7), dorsal pons (n = 6), medulla (n = 4), corpus callosum (n = 4), and cerebral white matter (n = 1). Brain stem lesions involved the following: tectum (n = 5), tegmentum (n = 4), red nucleus (n = 3) of the midbrain, vestibular nucleus (n = 6), and a focal tegmental lesion involving the superior olivary nucleus (n = 6) and abducens nucleus (n = 4) of the pons and vestibular nucleus (n = 4) and inferior olivary nucleus (n = 1) of the medulla. DWI (n = 5) showed isointensity or hyperintensity of lesions, and the decreased ADC value was found only in the corpus callosum lesions (n = 2). All detected lesions were completely reversible at follow-up except for the single corpus callosum lesion with an initial low ADC value.
CONCLUSION: Brain lesions were typically located at the cerebellar dentate nucleus, midbrain, dorsal pons, medulla, and splenium of the corpus callosum. According to DWI, most of the lesions in MIE probably corresponded to areas of vasogenic edema, whereas only some of them, located in the corpus callosum, corresponded to cytotoxic edema.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17885234      PMCID: PMC8134211          DOI: 10.3174/ajnr.A0655

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  39 in total

1.  Reversible metronidazole-induced lesions of the cerebellar dentate nuclei.

Authors:  Bryan K Woodruff; Eelco F M Wijdicks; William F Marshall
Journal:  N Engl J Med       Date:  2002-01-03       Impact factor: 91.245

2.  Wernicke encephalopathy: MR findings in five patients.

Authors:  M Gallucci; A Bozzao; A Splendiani; C Masciocchi; R Passariello
Journal:  AJR Am J Roentgenol       Date:  1990-12       Impact factor: 3.959

Review 3.  Acquired lesions of the corpus callosum: MR imaging.

Authors:  A Uchino; Y Takase; K Nomiyama; R Egashira; S Kudo
Journal:  Eur Radiol       Date:  2005-11-12       Impact factor: 5.315

4.  Reversible visual deficit and Corpus callosum lesions due to metronidazole toxicity.

Authors:  Jan L De Bleecker; Bart P Leroy; Veronique I Meire
Journal:  Eur Neurol       Date:  2005-04-26       Impact factor: 1.710

5.  Metronidazole neuropathy.

Authors:  W G Bradley; I J Karlsson; C G Rassol
Journal:  Br Med J       Date:  1977-09-03

6.  [Selective alterations of Purkinje cells in the dog after oral administration of high doses of nitroimidazole derivatives (author's transl)].

Authors:  K Schärer
Journal:  Verh Dtsch Ges Pathol       Date:  1972

7.  MR imaging findings of enteroviral encephaloymelitis: an outbreak in Taiwan.

Authors:  W C Shen; H H Chiu; K C Chow; C H Tsai
Journal:  AJNR Am J Neuroradiol       Date:  1999 Nov-Dec       Impact factor: 3.825

8.  Reversible cerebellar lesions induced by metronidazole therapy for helicobacter pylori.

Authors:  Hirono Ito; Michiyuki Maruyama; Naoko Ogura; Toshiki Fujioka; Yasuo Iwasaki; Atsushi Aikawa; Akira Hasegawa
Journal:  J Neuroimaging       Date:  2004-10       Impact factor: 2.486

9.  Diazepam as a treatment for metronidazole toxicosis in dogs: a retrospective study of 21 cases.

Authors:  Jason Evans; Donald Levesque; Kim Knowles; Randy Longshore; Scott Plummer
Journal:  J Vet Intern Med       Date:  2003 May-Jun       Impact factor: 3.333

10.  Model of Wernicke's encephalopathy.

Authors:  J C Troncoso; M V Johnston; K M Hess; J W Griffin; D L Price
Journal:  Arch Neurol       Date:  1981-06
View more
  66 in total

1.  Reversible cytotoxic oedema in the splenium of the corpus callosum related to tetracycline therapy.

Authors:  Barbara Grühbaum; Hans Salzer; Christian Nasel; Isolde Lernbass
Journal:  Pediatr Radiol       Date:  2010-08-06

2.  MR features of metronidazole-induced encephalopathy.

Authors:  Sonia Sandip; Ishrat Afshan; Rohit Kumar Khandelwal
Journal:  BMJ Case Rep       Date:  2015-10-05

3.  An 82-year-old man with ataxia and dysarthria.

Authors:  Lilian L Y Vivas; Wayne L Gold; Daniel M Mandell; Peter E Wu
Journal:  CMAJ       Date:  2015-10-13       Impact factor: 8.262

4.  Metronidazole-induced encephalopathy: a systematic review.

Authors:  Caspar Godthaab Sørensen; William Kristian Karlsson; Faisal Mohammad Amin; Mette Lindelof
Journal:  J Neurol       Date:  2018-12-07       Impact factor: 4.849

5.  Metronidazole-induced and Wernicke encephalopathy: two different entities sharing the same metabolic pathway?

Authors:  G Zuccoli; N Pipitone; D Santa Cruz
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-19       Impact factor: 3.825

6.  Cases: Reversible cerebellar syndrome caused by metronidazole.

Authors:  Justyna R Sarna; A Keith W Brownell; Sarah Furtado
Journal:  CMAJ       Date:  2009-09-14       Impact factor: 8.262

7.  Metronidazole-induced cerebellar toxicity.

Authors:  Jonathan A Chatzkel; Arastoo Vossough
Journal:  Pediatr Radiol       Date:  2009-11-14

8.  Isoniazid-induced cerebellitis: a disguised presentation.

Authors:  Prasant Peter; Mary John
Journal:  Singapore Med J       Date:  2014-01       Impact factor: 1.858

9.  Metronidazole-induced neurotoxicity presenting with sudden bilateral hearing loss, encephalopathy, and cerebellar dysfunction.

Authors:  Elmira Agah; Arman Habibi; Hamed Naderi; Abbas Tafakhori
Journal:  Eur J Clin Pharmacol       Date:  2016-10-15       Impact factor: 2.953

10.  Case report: MRI of the brain in metronidazole toxicity.

Authors:  Vishal Kalia; Kavita Saggar
Journal:  Indian J Radiol Imaging       Date:  2010-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.